Evidence map›Paper›PMID 40362624›Full record

ArticleInternational journal of molecular sciences2025

Analysis of the Expression and Activity of Cyclooxygenases COX-1 and COX-2 in THP-1 Monocytes and Macrophages Cultured with Xenogenic Collagen Matrices Biofunctionalized with the Injectable Platelet-Rich Fibrin.

Agnieszka Droździk, Katarzyna Barczak, Mateusz Bosiacki, Patrycja Kupnicka, Diana Cenariu, Willi Andrei Uriciuc, Dariusz Chlubek, Mariusz Lipski, Marek Droździk, Irena Baranowska-Bosiacka

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Agnieszka DroździkLaboratory of Preclinical Periodontology, Pomeranian Medical University in Szczecin, Powstańców Wlkp 72, 70-111 Szczecin, Poland.
Katarzyna BarczakDepartment of Conservative Dentistry and Endodontics, Pomeranian Medical University in Szczecin, Powstańców Wlkp 72, 70-111 Szczecin, Poland.
Mateusz BosiackiDepartment of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp 72, 70-111 Szczecin, Poland.ORCID 0000-0002-2279-4329
Patrycja KupnickaDepartment of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp 72, 70-111 Szczecin, Poland.ORCID 0000-0002-0756-6483
Diana CenariuMEDFUTURE-Research Center for Advanced Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
Willi Andrei UriciucFaculty of Nursing and Science of Health, "Iuliu-Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.ORCID 0000-0003-0044-6152
Dariusz ChlubekDepartment of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp 72, 70-111 Szczecin, Poland.ORCID 0000-0003-4497-4395
Mariusz LipskiDepartment of Preclinical Conservative Dentistry and Preclinical Endodontics, Pomeranian Medical University in Szczecin, Powstańców Wlkp 72, 70-111 Szczecin, Poland.
Marek DroździkDepartment of Experimental and Clinical Pharmacology, Pomeranian Medical University in Szczecin, Powstańców Wlkp 72, 70-111, Szczecin, Poland.ORCID 0000-0002-6191-7168
Irena Baranowska-BosiackaDepartment of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp 72, 70-111 Szczecin, Poland.ORCID 0000-0001-9187-8895

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xenogenic collagen matrices are used in clinical practice for soft tissue augmentation around teeth and implants, either alone or biofunctionalized with injectable platelet-rich fibrin (iPRF). Their direct interaction with inflammatory cells may influence both healing and destructive inflammation processes. Therefore, expression of cyclooxygenases (COX-1 and COX-2) and prostanoids (PGE2 and TXB2) was studied in THP-1 monocyte/macrophage cultures exposed to porcine collagen matrices (a non-cross-linked monolayer scaffold composed of collagen type I, collagen type III, and elastin (MLCM), a bilayer scaffold made of collagen types I and III (BLCM), and a volume-stable cross-linked monolayer scaffold (VSCM)). The study showed that VSCM and MLCM significantly reduced PGE2 concentrations in THP-1 monocyte cultures. iPRF further reduced PGE2 concentrations when exposed to MLCM. In contrast, incubation of THP-1 monocytes with VSCM and BLCM resulted in a significant increase in TXB2 concentrations compared with control conditions. Incubation of macrophages with MLCM, VSCM, and BLCM increased PGE2 concentrations, with VSCM and BLCM additionally increasing TXB2 concentrations. iPRF in macrophage cultures with VSCM and BLCM also resulted in increased PGE2 and TXB2 concentrations compared with control conditions. Confocal microscopy revealed no visible differences in COX-1 immunoexpression in monocytes and macrophages cultured with collagen matrices, either with or without iPFR. Weak positive COX-2 immunofluorescence was observed in monocytes, while moderate positive immunofluorescence was detected in macrophages. In conclusion, it can be suggested that the studied collagen matrices interact with monocytes/macrophages, with MLCM exhibiting the highest compatibility.

Indexed as

CollagenCyclooxygenase 1Cyclooxygenase 2MacrophagesMonocytesPlatelet-Rich FibrinAnimalsDinoprostoneHumansSwineTHP-1 CellsTissue ScaffoldsCollagenCyclooxygenase 1Cyclooxygenase 2DinoprostonePTGS1 protein, humanPTGS2 protein, humancyclooxygenase-1 (COX-1)cyclooxygenase-2 (COX-2)inflammatory reactioninjectable platelet-rich fibrin (iPRF)macrophagesTHP-1 monocytesxenogenic collagen matrices

Identifiers

PMID40362624
PMCPMC12073069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.